[(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate

C21H21N6O11P — CID 136721472

IUPAC[(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate
SMILESCC(=O)Nc1nc2c(ncn2[C@H]2C[C@H](OC(C)=O)[C@@H](COP3(=O)OCc4cc([N+](=O)[O-])ccc4O3)O2)c(=O)[nH]1
InChIInChI=1S/C21H21N6O11P/c1-10(28)23-21-24-19-18(20(30)25-21)22-9-26(19)17-6-15(36-11(2)29)16(37-17)8-35-39(33)34-7-12-5-13(27(31)32)3-4-14(12)38-39/h3-5,9,15-17H,6-8H2,1-2H3,(H2,23,24,25,28,30)/t15-,16+,17+,39?/m0/s1
InChIKeyWCKKSETUPUSLSQ-PMQRHDGXSA-N
MW564.40 g/mol
LogP1.94
Rot. Bonds7

About [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate

[(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate (PubChem CID 136721472) has the molecular formula C21H21N6O11P and a molecular weight of 564.40 g/mol. Its IUPAC name is [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate.

Molecular Properties

Compound Name[(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate
PubChem CID136721472
Molecular FormulaC21H21N6O11P
Molecular Weight564.40 g/mol
Exact Mass564.10
IUPAC Name[(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate
SMILESCC(=O)Nc1nc2c(ncn2[C@H]2C[C@H](OC(C)=O)[C@@H](COP3(=O)OCc4cc([N+](=O)[O-])ccc4O3)O2)c(=O)[nH]1
InChIInChI=1S/C21H21N6O11P/c1-10(28)23-21-24-19-18(20(30)25-21)22-9-26(19)17-6-15(36-11(2)29)16(37-17)8-35-39(33)34-7-12-5-13(27(31)32)3-4-14(12)38-39/h3-5,9,15-17H,6-8H2,1-2H3,(H2,23,24,25,28,30)/t15-,16+,17+,39?/m0/s1
InChIKeyWCKKSETUPUSLSQ-PMQRHDGXSA-N
XLogP1.94
TPSA216.10 Ų
H-Bond Donors2
H-Bond Acceptors14
Rotatable Bonds7
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500564.40
LogP ≤ 51.94
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate?
The IUPAC name of [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate (CID 136721472) is [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate.
What is the SMILES notation for [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate?
The canonical SMILES for [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate is CC(=O)Nc1nc2c(ncn2[C@H]2C[C@H](OC(C)=O)[C@@H](COP3(=O)OCc4cc([N+](=O)[O-])ccc4O3)O2)c(=O)[nH]1.
What is the InChIKey of [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate?
The InChIKey is WCKKSETUPUSLSQ-PMQRHDGXSA-N. The full InChI is InChI=1S/C21H21N6O11P/c1-10(28)23-21-24-19-18(20(30)25-21)22-9-26(19)17-6-15(36-11(2)29)16(37-17)8-35-39(33)34-7-12-5-13(27(31)32)3-4-14(12)38-39/h3-5,9,15-17H,6-8H2,1-2H3,(H2,23,24,25,28,30)/t15-,16+,17+,39?/m0/s1.
What are the key properties of [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate?
[(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate has a molecular weight of 564.40 g/mol, XLogP of 1.94, 7 rotatable bonds, 2 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3S,5R)-5-(2-acetamido-6-oxo-1H-purin-9-yl)-2-[(6-nitro-2-oxo-4H-1,3,2λ5-benzodioxaphosphinin-2-yl)oxymethyl]oxolan-3-yl] acetate is sourced from PubChem (CID 136721472), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).